Related Experiment Video

Updated: Oct 14, 2025

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

17.0K

Severe congenital neutropenia with elastase, neutrophil expressed (ELANE) gene mutation in a Tanzanian child

Aika Shoo1,2, Peter Swai1, Christine Kindole1

  • 1Department of Paediatrics and Child Health, Muhimbili National Hospital (MNH), Dar-es-Salaam, Tanzania.

British Journal of Haematology
|November 2, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
childhoodelastase, neutrophil expressed genefevergranulocyte-colony stimulating factorsevere congenital neutropenia

More Related Videos

Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis
04:30

Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis

Published on: January 17, 2025

1.4K
Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
07:18

Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA

Published on: May 12, 2023

3.9K

Related Experiment Videos

Last Updated: Oct 14, 2025

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

17.0K
Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis
04:30

Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis

Published on: January 17, 2025

1.4K
Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
07:18

Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA

Published on: May 12, 2023

3.9K

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

328
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
328

Articles linked to this work by shared authors, journal, and citation graph.

Structural insights into RNA phosphorylation by the RNase PNK module of the human rixosome complex.

Nucleic acids research·2026

Congenital Pulmonary Airway Malformation Presenting as Pneumothorax: Two Case Reports.

Case reports in pediatrics·2026

Bridging the gap: to what extent are mental health services available in HIV Care and Treatment Centres in Tanzania? A cross-sectional facility-based baseline survey.

BMJ open·2026

Complement inhibitor therapy should be available to patients with paroxysmal nocturnal hemoglobinuria throughout the world.

International journal of hematology·2026

Prothrombinase processivity is conferred by substrate allostery.

The EMBO journal·2026

Detection of bronchoesophageal fistula in an infant: a case report.

The Pan African medical journal·2026

Ibrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.

British journal of haematology·2026

Prospective evaluation of serum methotrexate pharmacokinetics following intrathecal methotrexate in acute lymphoblastic leukaemia.

British journal of haematology·2026

Mogamulizumab efficacy on the skin compartment of cutaneous T-cell lymphomas based on longitudinal analysis.

British journal of haematology·2026

CAR-HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B-cell non-Hodgkin lymphoma.

British journal of haematology·2026

Patient-specific genomic measurable residual disease markers for monitoring acute myeloid leukaemia and myeloid malignancy.

British journal of haematology·2026

A real-world multi-institution experience of standard versus alternative dosing regimens of inotuzumab ozogamicin for relapsed/refractory paediatric B-cell acute lymphoblastic leukaemia.

British journal of haematology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us